OBJECTIVE: Obesity is associated with increased risk for cardiovascular diseases and peripheral endothelial dysfunction. We examined whether myocardial vasoreactivity and coronary-flow response to insulin stimulation are altered in obesity. RESEARCH METHODS AND PROCEDURES: Myocardial blood flow was quantitated in 10 obese men (body mass index, 33.6 +/- 1.9 kg/m(2)) and 10 healthy matched non-obese men (body mass index, 24.2 +/- 1.9 kg/m(2)), using positron emission tomography and oxygen-15-labeled water. The measurements were performed basally and during adenosine infusion (140 microg/kg per minute), with or without simultaneous physiological (1 mU/kg per minute) and supraphysiological (5 mU/kg per minute) hyperinsulinemia. RESULTS: Basal myocardial blood flow was not significantly different between obese and non-obese subjects. Adenosine-stimulated flow was blunted in obese (3.2 +/- 0.6 mL/g per minute) when compared with non-obese subjects (4.0 +/- 1.1 mL/g per minute, p < 0.05). Simultaneous physiological hyperinsulinemia increased adenosine-stimulated myocardial flow significantly in both groups (to 4.03 +/- 1.24 and 4.85 +/- 1.04 mL/g per minute in obese and non-obese men, respectively; p < 0.05 vs. adenosine). Supraphysiological hyperinsulinemia further enhanced the adenosine-stimulated flow in non-obese subjects (to 5.56 +/- 0.98 mL/g per minute; p < 0.05) but not in obese subjects. DISCUSSION: Young obese, healthy men have reduced myocardial vasoreactivity, which may represent an early precursor of future coronary artery disease. Additionally, insulin-induced enhancement of myocardial blood flow is blunted in obesity. Thus, endothelial dysfunction seems to also characterize myocardial vasculature of obese subjects.
OBJECTIVE:Obesity is associated with increased risk for cardiovascular diseases and peripheral endothelial dysfunction. We examined whether myocardial vasoreactivity and coronary-flow response to insulin stimulation are altered in obesity. RESEARCH METHODS AND PROCEDURES: Myocardial blood flow was quantitated in 10 obesemen (body mass index, 33.6 +/- 1.9 kg/m(2)) and 10 healthy matched non-obesemen (body mass index, 24.2 +/- 1.9 kg/m(2)), using positron emission tomography and oxygen-15-labeled water. The measurements were performed basally and during adenosine infusion (140 microg/kg per minute), with or without simultaneous physiological (1 mU/kg per minute) and supraphysiological (5 mU/kg per minute) hyperinsulinemia. RESULTS: Basal myocardial blood flow was not significantly different between obese and non-obese subjects. Adenosine-stimulated flow was blunted in obese (3.2 +/- 0.6 mL/g per minute) when compared with non-obese subjects (4.0 +/- 1.1 mL/g per minute, p < 0.05). Simultaneous physiological hyperinsulinemia increased adenosine-stimulated myocardial flow significantly in both groups (to 4.03 +/- 1.24 and 4.85 +/- 1.04 mL/g per minute in obese and non-obesemen, respectively; p < 0.05 vs. adenosine). Supraphysiological hyperinsulinemia further enhanced the adenosine-stimulated flow in non-obese subjects (to 5.56 +/- 0.98 mL/g per minute; p < 0.05) but not in obese subjects. DISCUSSION: Young obese, healthy men have reduced myocardial vasoreactivity, which may represent an early precursor of future coronary artery disease. Additionally, insulin-induced enhancement of myocardial blood flow is blunted in obesity. Thus, endothelial dysfunction seems to also characterize myocardial vasculature of obese subjects.
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: Eduardo Cavalcanti Lapa Santos; J M Del Castillo; G B O Parente; R P Pedrosa; P S Gadelha; R D Lopes; F Kreimer; F R M Neto Journal: Obes Surg Date: 2020-02 Impact factor: 4.129
Authors: Riikka Lautamäki; Richard T George; Kakuya Kitagawa; Takahiro Higuchi; Jennifer Merrill; Corina Voicu; Anthony DiPaula; Stephan G Nekolla; João A C Lima; Albert C Lardo; Frank M Bengel Journal: Eur J Nucl Med Mol Imaging Date: 2008-11-05 Impact factor: 9.236
Authors: Linda R Peterson; Pablo F Soto; Pilar Herrero; B Selma Mohammed; Michael S Avidan; Kenneth B Schechtman; Carmen Dence; Robert J Gropler Journal: JACC Cardiovasc Imaging Date: 2008-07
Authors: Danijela Trifunovic; Sanja Stankovic; Dragana Sobic-Saranovic; Jelena Marinkovic; Marija Petrovic; Dejan Orlic; Branko Beleslin; Marko Banovic; Bosiljka Vujisic-Tesic; Milan Petrovic; Ivana Nedeljkovic; Jelena Stepanovic; Ana Djordjevic-Dikic; Milorad Tesic; Nina Djukanovic; Olga Petrovic; Olga Vasovic; Emilija Nestorovic; Jelena Kostic; Arsen Ristic; Miodrag Ostojic Journal: Cardiovasc Diabetol Date: 2014-04-05 Impact factor: 9.951